aluates Reports

$ 0.0

Automative

Global Clotting Factors Ⅷ Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-21S8513

Global Clotting Factors Ⅷ Market Insights Forecast to 2028

BUY CHAPTERS

Global Clotting Factors Ⅷ Market Research Report 2025

Code: QYRE-Auto-21S8513

Report

September 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lvshizi

Taibang Biological

Shanghai Laishi

Hualan Biological

Clotting Factors Ⅷ Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Clotting Factors Ⅷ Market

The global market for Clotting Factors Ⅷ was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Clotting Factors Ⅷ, this product for a lack of blood coagulation factor of blood coagulation dysfunction caused by Ⅷ have corrective effect, mainly used for the prevention of influenza a hemophilia and acquired Ⅷ lack of clotting factors and causes of bleeding symptoms and surgical bleeding treatment of these patients.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Clotting Factors Ⅷ, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clotting Factors Ⅷ.

The Clotting Factors Ⅷ market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clotting Factors Ⅷ market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Clotting Factors Ⅷ manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Clotting Factors Ⅷ Market Report

Report Metric	Details
Report Name	Clotting Factors Ⅷ Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Injection Freeze-dried Injection
Segment by Application	Hemophilia A Bleeding Diseases
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Lvshizi, Taibang Biological, Shanghai Laishi, Hualan Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clotting Factors Ⅷ manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clotting Factors Ⅷ in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Clotting Factors Ⅷ Market report?

Ans: The main players in the Clotting Factors Ⅷ Market are Lvshizi, Taibang Biological, Shanghai Laishi, Hualan Biological

What are the Application segmentation covered in the Clotting Factors Ⅷ Market report?

Ans: The Applications covered in the Clotting Factors Ⅷ Market report are Hemophilia A, Bleeding Diseases

What are the Type segmentation covered in the Clotting Factors Ⅷ Market report?

Ans: The Types covered in the Clotting Factors Ⅷ Market report are Injection, Freeze-dried Injection

Recommended Reports

Hemostasis Solutions

Coagulation Testing

Blood Management

1 Clotting Factors Ⅷ Market Overview

1.1 Product Definition

1.2 Clotting Factors Ⅷ by Type

1.2.1 Global Clotting Factors Ⅷ Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injection

1.2.3 Freeze-dried Injection

1.3 Clotting Factors Ⅷ by Application

1.3.1 Global Clotting Factors Ⅷ Market Value by Application (2024 VS 2031)

1.3.2 Hemophilia A

1.3.3 Bleeding Diseases

1.4 Global Clotting Factors Ⅷ Market Size Estimates and Forecasts

1.4.1 Global Clotting Factors Ⅷ Revenue 2020-2031

1.4.2 Global Clotting Factors Ⅷ Sales 2020-2031

1.4.3 Global Clotting Factors Ⅷ Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Clotting Factors Ⅷ Market Competition by Manufacturers

2.1 Global Clotting Factors Ⅷ Sales Market Share by Manufacturers (2020-2025)

2.2 Global Clotting Factors Ⅷ Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Clotting Factors Ⅷ Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Clotting Factors Ⅷ, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Clotting Factors Ⅷ, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Clotting Factors Ⅷ, Product Type & Application

2.7 Global Key Manufacturers of Clotting Factors Ⅷ, Date of Enter into This Industry

2.8 Global Clotting Factors Ⅷ Market Competitive Situation and Trends

2.8.1 Global Clotting Factors Ⅷ Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Clotting Factors Ⅷ Players Market Share by Revenue

2.8.3 Global Clotting Factors Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Clotting Factors Ⅷ Market Scenario by Region

3.1 Global Clotting Factors Ⅷ Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Clotting Factors Ⅷ Sales by Region: 2020-2031

3.2.1 Global Clotting Factors Ⅷ Sales by Region: 2020-2025

3.2.2 Global Clotting Factors Ⅷ Sales by Region: 2026-2031

3.3 Global Clotting Factors Ⅷ Revenue by Region: 2020-2031

3.3.1 Global Clotting Factors Ⅷ Revenue by Region: 2020-2025

3.3.2 Global Clotting Factors Ⅷ Revenue by Region: 2026-2031

3.4 North America Clotting Factors Ⅷ Market Facts & Figures by Country

3.4.1 North America Clotting Factors Ⅷ Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Clotting Factors Ⅷ Sales by Country (2020-2031)

3.4.3 North America Clotting Factors Ⅷ Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Clotting Factors Ⅷ Market Facts & Figures by Country

3.5.1 Europe Clotting Factors Ⅷ Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Clotting Factors Ⅷ Sales by Country (2020-2031)

3.5.3 Europe Clotting Factors Ⅷ Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Clotting Factors Ⅷ Market Facts & Figures by Region

3.6.1 Asia Pacific Clotting Factors Ⅷ Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Clotting Factors Ⅷ Sales by Region (2020-2031)

3.6.3 Asia Pacific Clotting Factors Ⅷ Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Clotting Factors Ⅷ Market Facts & Figures by Country

3.7.1 Latin America Clotting Factors Ⅷ Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Clotting Factors Ⅷ Sales by Country (2020-2031)

3.7.3 Latin America Clotting Factors Ⅷ Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Clotting Factors Ⅷ Market Facts & Figures by Country

3.8.1 Middle East and Africa Clotting Factors Ⅷ Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Clotting Factors Ⅷ Sales by Country (2020-2031)

3.8.3 Middle East and Africa Clotting Factors Ⅷ Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Clotting Factors Ⅷ Sales by Type (2020-2031)

4.1.1 Global Clotting Factors Ⅷ Sales by Type (2020-2025)

4.1.2 Global Clotting Factors Ⅷ Sales by Type (2026-2031)

4.1.3 Global Clotting Factors Ⅷ Sales Market Share by Type (2020-2031)

4.2 Global Clotting Factors Ⅷ Revenue by Type (2020-2031)

4.2.1 Global Clotting Factors Ⅷ Revenue by Type (2020-2025)

4.2.2 Global Clotting Factors Ⅷ Revenue by Type (2026-2031)

4.2.3 Global Clotting Factors Ⅷ Revenue Market Share by Type (2020-2031)

4.3 Global Clotting Factors Ⅷ Price by Type (2020-2031)

5 Segment by Application

5.1 Global Clotting Factors Ⅷ Sales by Application (2020-2031)

5.1.1 Global Clotting Factors Ⅷ Sales by Application (2020-2025)

5.1.2 Global Clotting Factors Ⅷ Sales by Application (2026-2031)

5.1.3 Global Clotting Factors Ⅷ Sales Market Share by Application (2020-2031)

5.2 Global Clotting Factors Ⅷ Revenue by Application (2020-2031)

5.2.1 Global Clotting Factors Ⅷ Revenue by Application (2020-2025)

5.2.2 Global Clotting Factors Ⅷ Revenue by Application (2026-2031)

5.2.3 Global Clotting Factors Ⅷ Revenue Market Share by Application (2020-2031)

5.3 Global Clotting Factors Ⅷ Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Lvshizi

6.1.1 Lvshizi Company Information

6.1.2 Lvshizi Description and Business Overview

6.1.3 Lvshizi Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Lvshizi Clotting Factors Ⅷ Product Portfolio

6.1.5 Lvshizi Recent Developments/Updates

6.2 Taibang Biological

6.2.1 Taibang Biological Company Information

6.2.2 Taibang Biological Description and Business Overview

6.2.3 Taibang Biological Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Taibang Biological Clotting Factors Ⅷ Product Portfolio

6.2.5 Taibang Biological Recent Developments/Updates

6.3 Shanghai Laishi

6.3.1 Shanghai Laishi Company Information

6.3.2 Shanghai Laishi Description and Business Overview

6.3.3 Shanghai Laishi Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shanghai Laishi Clotting Factors Ⅷ Product Portfolio

6.3.5 Shanghai Laishi Recent Developments/Updates

6.4 Hualan Biological

6.4.1 Hualan Biological Company Information

6.4.2 Hualan Biological Description and Business Overview

6.4.3 Hualan Biological Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hualan Biological Clotting Factors Ⅷ Product Portfolio

6.4.5 Hualan Biological Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Clotting Factors Ⅷ Industry Chain Analysis

7.2 Clotting Factors Ⅷ Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Clotting Factors Ⅷ Production Mode & Process Analysis

7.4 Clotting Factors Ⅷ Sales and Marketing

7.4.1 Clotting Factors Ⅷ Sales Channels

7.4.2 Clotting Factors Ⅷ Distributors

7.5 Clotting Factors Ⅷ Customer Analysis

8 Clotting Factors Ⅷ Market Dynamics

8.1 Clotting Factors Ⅷ Industry Trends

8.2 Clotting Factors Ⅷ Market Drivers

8.3 Clotting Factors Ⅷ Market Challenges

8.4 Clotting Factors Ⅷ Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Lvshizi

Taibang Biological

Shanghai Laishi

Hualan Biological

List of Tables

Table 1. Global Clotting Factors Ⅷ Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Clotting Factors Ⅷ Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Clotting Factors Ⅷ Market Competitive Situation by Manufacturers in 2024

Table 4. Global Clotting Factors Ⅷ Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Clotting Factors Ⅷ Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Clotting Factors Ⅷ Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Clotting Factors Ⅷ Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Clotting Factors Ⅷ Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Clotting Factors Ⅷ, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Clotting Factors Ⅷ, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Clotting Factors Ⅷ, Product Type & Application

Table 12. Global Key Manufacturers of Clotting Factors Ⅷ, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Clotting Factors Ⅷ by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clotting Factors Ⅷ as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Clotting Factors Ⅷ Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Clotting Factors Ⅷ Sales by Region (2020-2025) & (K Units)

Table 18. Global Clotting Factors Ⅷ Sales Market Share by Region (2020-2025)

Table 19. Global Clotting Factors Ⅷ Sales by Region (2026-2031) & (K Units)

Table 20. Global Clotting Factors Ⅷ Sales Market Share by Region (2026-2031)

Table 21. Global Clotting Factors Ⅷ Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Clotting Factors Ⅷ Revenue Market Share by Region (2020-2025)

Table 23. Global Clotting Factors Ⅷ Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Clotting Factors Ⅷ Revenue Market Share by Region (2026-2031)

Table 25. North America Clotting Factors Ⅷ Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Clotting Factors Ⅷ Sales by Country (2020-2025) & (K Units)

Table 27. North America Clotting Factors Ⅷ Sales by Country (2026-2031) & (K Units)

Table 28. North America Clotting Factors Ⅷ Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Clotting Factors Ⅷ Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Clotting Factors Ⅷ Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Clotting Factors Ⅷ Sales by Country (2020-2025) & (K Units)

Table 32. Europe Clotting Factors Ⅷ Sales by Country (2026-2031) & (K Units)

Table 33. Europe Clotting Factors Ⅷ Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Clotting Factors Ⅷ Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Clotting Factors Ⅷ Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Clotting Factors Ⅷ Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Clotting Factors Ⅷ Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Clotting Factors Ⅷ Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Clotting Factors Ⅷ Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Clotting Factors Ⅷ Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Clotting Factors Ⅷ Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Clotting Factors Ⅷ Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Clotting Factors Ⅷ Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Clotting Factors Ⅷ Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Clotting Factors Ⅷ Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Clotting Factors Ⅷ Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Clotting Factors Ⅷ Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Clotting Factors Ⅷ Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Clotting Factors Ⅷ Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Clotting Factors Ⅷ Sales (K Units) by Type (2020-2025)

Table 51. Global Clotting Factors Ⅷ Sales (K Units) by Type (2026-2031)

Table 52. Global Clotting Factors Ⅷ Sales Market Share by Type (2020-2025)

Table 53. Global Clotting Factors Ⅷ Sales Market Share by Type (2026-2031)

Table 54. Global Clotting Factors Ⅷ Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Clotting Factors Ⅷ Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Clotting Factors Ⅷ Revenue Market Share by Type (2020-2025)

Table 57. Global Clotting Factors Ⅷ Revenue Market Share by Type (2026-2031)

Table 58. Global Clotting Factors Ⅷ Price (US$/Unit) by Type (2020-2025)

Table 59. Global Clotting Factors Ⅷ Price (US$/Unit) by Type (2026-2031)

Table 60. Global Clotting Factors Ⅷ Sales (K Units) by Application (2020-2025)

Table 61. Global Clotting Factors Ⅷ Sales (K Units) by Application (2026-2031)

Table 62. Global Clotting Factors Ⅷ Sales Market Share by Application (2020-2025)

Table 63. Global Clotting Factors Ⅷ Sales Market Share by Application (2026-2031)

Table 64. Global Clotting Factors Ⅷ Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Clotting Factors Ⅷ Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Clotting Factors Ⅷ Revenue Market Share by Application (2020-2025)

Table 67. Global Clotting Factors Ⅷ Revenue Market Share by Application (2026-2031)

Table 68. Global Clotting Factors Ⅷ Price (US$/Unit) by Application (2020-2025)

Table 69. Global Clotting Factors Ⅷ Price (US$/Unit) by Application (2026-2031)

Table 70. Lvshizi Company Information

Table 71. Lvshizi Description and Business Overview

Table 72. Lvshizi Clotting Factors Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Lvshizi Clotting Factors Ⅷ Product

Table 74. Lvshizi Recent Developments/Updates

Table 75. Taibang Biological Company Information

Table 76. Taibang Biological Description and Business Overview

Table 77. Taibang Biological Clotting Factors Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Taibang Biological Clotting Factors Ⅷ Product

Table 79. Taibang Biological Recent Developments/Updates

Table 80. Shanghai Laishi Company Information

Table 81. Shanghai Laishi Description and Business Overview

Table 82. Shanghai Laishi Clotting Factors Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Shanghai Laishi Clotting Factors Ⅷ Product

Table 84. Shanghai Laishi Recent Developments/Updates

Table 85. Hualan Biological Company Information

Table 86. Hualan Biological Description and Business Overview

Table 87. Hualan Biological Clotting Factors Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Hualan Biological Clotting Factors Ⅷ Product

Table 89. Hualan Biological Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Clotting Factors Ⅷ Distributors List

Table 93. Clotting Factors Ⅷ Customers List

Table 94. Clotting Factors Ⅷ Market Trends

Table 95. Clotting Factors Ⅷ Market Drivers

Table 96. Clotting Factors Ⅷ Market Challenges

Table 97. Clotting Factors Ⅷ Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Clotting Factors Ⅷ

Figure 2. Global Clotting Factors Ⅷ Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Clotting Factors Ⅷ Market Share by Type: 2024 & 2031

Figure 4. Injection Product Picture

Figure 5. Freeze-dried Injection Product Picture

Figure 6. Global Clotting Factors Ⅷ Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Clotting Factors Ⅷ Market Share by Application: 2024 & 2031

Figure 8. Hemophilia A

Figure 9. Bleeding Diseases

Figure 10. Global Clotting Factors Ⅷ Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Clotting Factors Ⅷ Market Size (2020-2031) & (US$ Million)

Figure 12. Global Clotting Factors Ⅷ Sales (2020-2031) & (K Units)

Figure 13. Global Clotting Factors Ⅷ Average Price (US$/Unit) & (2020-2031)

Figure 14. Clotting Factors Ⅷ Report Years Considered

Figure 15. Clotting Factors Ⅷ Sales Share by Manufacturers in 2024

Figure 16. Global Clotting Factors Ⅷ Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Clotting Factors Ⅷ Players: Market Share by Revenue in Clotting Factors Ⅷ in 2024

Figure 18. Clotting Factors Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Clotting Factors Ⅷ Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Clotting Factors Ⅷ Sales Market Share by Country (2020-2031)

Figure 21. North America Clotting Factors Ⅷ Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Clotting Factors Ⅷ Sales Market Share by Country (2020-2031)

Figure 25. Europe Clotting Factors Ⅷ Revenue Market Share by Country (2020-2031)

Figure 26. Germany Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Clotting Factors Ⅷ Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Clotting Factors Ⅷ Revenue Market Share by Region (2020-2031)

Figure 33. China Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Clotting Factors Ⅷ Sales Market Share by Country (2020-2031)

Figure 44. Latin America Clotting Factors Ⅷ Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Clotting Factors Ⅷ Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Clotting Factors Ⅷ Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Clotting Factors Ⅷ Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Clotting Factors Ⅷ by Type (2020-2031)

Figure 54. Global Revenue Market Share of Clotting Factors Ⅷ by Type (2020-2031)

Figure 55. Global Clotting Factors Ⅷ Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Clotting Factors Ⅷ by Application (2020-2031)

Figure 57. Global Revenue Market Share of Clotting Factors Ⅷ by Application (2020-2031)

Figure 58. Global Clotting Factors Ⅷ Price (US$/Unit) by Application (2020-2031)

Figure 59. Clotting Factors Ⅷ Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coagulometer Market Insights Forecast to 2030

Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coagulants Market Research Report 2024

Global Coagulation Factor Concentrates Market Research Report 2024

Coagulation Factor II Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Coagulation Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Coagulation Factor IV Market Research Report 2024

Blood Coagulators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Whole Blood Coagulation Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostatic Agents Market Research Report 2025

Global Powder Hemostatic Agent Market Insights Forecast to 2030

Global Haemophilia Treatment Market Insights Forecast to 2030

Blood Clotting Accelerant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Organic Coagulant Market Insights Forecast to 2030

Global Clotting Factor Market Research Report 2025

Global Disposable Hemostatic Agents Market Insights Forecast to 2030

Global Blood Clotting Aids Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions